TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
PLRX

Pliant Therapeutics Inc

Healthcare · Biotechnology

1.10$ +0.0% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Pliant Therapeutics Inc (PLRX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 88.9% of the shares are freely tradable; institutional investors hold 81.9%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 81.9%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 2.3%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 88.9%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 5.4%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 62Mio.

Largest Shareholders

Institutions

Institutions PLRX
Name Stake (%) Shares Change (%) Date
TANG CAPITAL MANAGEMENT LLC 9.92 6,143,132 +0.0 03/31/2026
ADAR1 Capital Management LLC 4.17 2,585,126 +3,402.0 03/31/2026
Acadian Asset Management LLC 3.90 2,416,508 +445,750.2 03/31/2026
Vanguard Capital Management, LLC 3.78 2,343,101 +0.0 03/31/2026
Two Sigma Investments LLC 3.65 2,262,832 +0.4 06/30/2026
Citadel Advisors Llc 3.46 2,142,226 -33.6 06/30/2026
Monaco Asset Management 3.13 1,938,747 +0.0 06/30/2026
Renaissance Technologies Corp 2.99 1,852,842 +77.2 03/31/2026
Lynx1 Capital Management, LP 2.90 1,798,070 +0.0 06/30/2026

Funds

Funds PLRX
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 2.82 1,746,470 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?